Acasti Pharma (CVE:ACST) Shares Up 1.8%

trading, an increase of 3% from the average session volume of 2,383 shares. The stock had previously closed at C$0.57. The stock of Acasti Pharma Inc. (CVE:ACST) shot up 1.8% during trading on Tuesday. 2,450 shares traded hands during mid-day trading, an increase of 3% from the average session vo

The stock price of jumped 1.8% on Tuesday. The company reached a high of C$0.58 before trading at C$0.58. Mid-day trading saw 2,450 shares change hands, which is a 63% decrease from the session average of 6,576. The stock closed previously at C$0.57.

Acasti Pharma Stock Price

The company's market capitalization is C$25.87m, with a P/E ratio of -1.07, and a beta value of 1.22. The company's current ratio is 9.74, its quick ratio is 9.41, and it has a debt to equity ratio of 0.52 The stock's simple moving-average of C$0.67 is higher than its simple moving-average of C$0.72.

A Casti Pharma

Get Rating

Acasti Pharma Inc is a biopharmaceutical firm that develops and markets pharmaceutical products to treat cardiovascular diseases. CaPre is currently being evaluated for strategic partnerships. The company was founded in 2002, and its headquarters are located in Laval in Canada. offers a FREE daily email newsletter